NASDAQ:CASC Investor Alert: Investigation of Takeover of Cascadian Therapeutics Inc
February 05, 2018 at 12:15 PM EST
San Diego, CA -- (SBWIRE) -- 02/05/2018 -- The takeover of Cascadian Therapeutics Inc is under investigation over possible wrongdoing. The investigation was announced for investors, who currently hold NASDAQ:CASC shares, concerning whether the takeover of Cascadian Therapeutics Inc by Seattle Genetics, Inc for $10.00 per share is unfair.